Tumour suppressor gene function in carcinoma-associated fibroblasts: From tumour cells via EMT and back again?

Journal of Pathology

Volumn 232, Issue 3, 2014, Pages 283-288

  Drake, Lauren E ^a,b   Macleod, Kay F ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

carcinoma associated fibroblasts; EMT; lineage tracing; micro RNAs; p53; Pten; RB; TGF ; trophic support

Indexed keywords

CHEMOKINE; GROWTH FACTOR; MICRORNA;

CARCINOMA ASSOCIATED FIBROBLAST; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE;

EID: 84892389982     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4298     Document Type: Review

References (55)

1. Coussens LM, Hanahan D,. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
2. Gatenby RA, Gillies RJ,. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008; 8: 56-61.
3. Yates LR, Campbell PJ,. Evolution of the cancer genome. Nat Rev Genet 2012; 13: 795-806.
4. Gillies RJ, Verduzco D, Gatenby RA,. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 2012; 12: 487-493.
5. Moinfar F, Man YG, Arnould L, et al., Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000; 60: 2562-2566.
6. Kurose K, Gilley K, Matsumoto S, et al., Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Gen 2002; 32: 355-357.
7. Fukino K, Shen L, Matsumoto S, et al., Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 2004; 64: 7231-7236.
8. Patocs A, Zhang L, Xu Y, et al., Breast-cancer stromal cells with TP53 mutations and nodal metastases. New Engl J Med 2007; 357: 2543-2551.
9. Wernert N, Löcherbach C, Wellmann A, et al., Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 2001; 21: 2259-2264.
10. Tuhkanen H, Anttila M, Kosma VM, et al., Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 2004; 109: 247-245.
11. Paterson RF, Ulbright TM, MacLennan GT, et al., Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Cancer 2003; 98: 1830-1836.
12. Hu M, Yao J, Cai L, et al., Distinct epigenetic changes in the stromal cells of breast cancers. Nat Gen 2005; 37: 899-905.
13. Bhowmick NA, Chytil A, Plieth D, et al., TGFβ signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-851.
14. + T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16: 91-102.
15. Olumi AF, Grossfeld GD, Hayward SW, et al., Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-5011.
16. Kuperwasser C, Chavarria T, Wu M, et al., Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971.
17. Hayward SW, Wang Y, Cao M, et al., Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001; 61: 8135-8142.
18. Bhowmick NA, Neilson EG, Moses HL,. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
19. Orimo A, Gupta PB, Sgroi DC, et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
20. Kalluri R., Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
21. Ohuchida K, Mizumoto K, Murakami M, et al., Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004; 64: 3215-3222.
22. Krtolica A, Parrinello S, Lockett S, et al., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072-12077.
23. Capparelli C, Guido C, Whitaker-Menezes D, et al., Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 2012; 11: 2285-2302.
24. Kuilman T, Peeper DS,. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
25. Karnoub AE, Dash AB, Vo AP, et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
26. Mitra AK, Zillhardt M, Hua Y, et al., MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2012; 2: 1100-1108.
27. Chang HY, Chi JT, Dudoit S, et al., Diversity, topographic differentiation and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
28. Rinn JL, Bondre C, Gladstone HB, et al., Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2006; 2: 1084-1096.
29. Sugimoto H, Mundell TM, Kieran MW, et al., Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5: 1640-1646.
30. Orimo A, Weinberg RA,. Heterogeneity of stromal fibroblasts in tumors. Cancer Biol Ther 2007; 6: e1.
31. + fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation. Am J Path 2011; 178: 382-390.
32. Pickard A, Cichon AC, Barry A, et al., Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion. EMBO J 2012; 31: 3092-3103.
33. Hill R, Song Y, Cardiff RD, et al., Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005; 123: 1001-1011.
34. Trimboli AJ, Cantemir-Stone CZ, Li F, et al., Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461: 1084-1091.
35. Bronisz A, Godlewski J, Wallace JA, et al., Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-321. Nat Cell Biol 2012; 14: 159-167.
36. Pickard A, Cichon AC, Menges C, et al., Regulation of epithelial differentiation and proliferation by the stroma: a role for the retinoblastoma protein. J Invest Dermatol 2012; 132: 2691-2699.
37. Liu H, Knabb JR, Spike BT, et al., Elevated Parp activity sensitizes Rb deficient cells to DNA damage-induced necrosis. Mol Cancer Res 2009; 7: 1099-1109.
38. Cichon AC, Pickard A, McDade SS, et al., AKT in stromal fibroblasts controls invasion of epithelial cells. Oncotarget 2013; 4: 1103-1116.
39. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615.
40. Littlepage LE, Egeblad M, Werb Z,. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005; 7: 499-500.
41. Orimo A, Weinberg RA,. Stromal fibroblasts in cancer. Cell Cycle 2006; 5: 1597-1601.
42. Hosein AN, Wu M, Arcand SL, et al., Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations. Cancer Res 2010; 70: 5770-5777.
43. Rhim AD, Mirek ET, Aiello NM, et al., EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349-361.
44. Guerra C, Collado M, Navas C, et al., Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-739.
45. Thiery JP, Acloque H, Huang RYJ, et al., Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
46. Polyak K, Weinberg RA,. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
47. Ikushima H, Miyazono K,. TGFβ signaling: a complex web in cancer progression. Nat Rev Cancer 2010; 10: 415-424.
48. Chang CJ, Chao CH, Xia W, et al., p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13: 317-323.
49. Pinho AV, Rooman I, Real FX,. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle 2011; 10: 1312-1321.
50. Zhang Y, Yan W, Chen X,. Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions. J Biol Chem 2011; 286: 16218-16228.
51. Arima Y, Inoue Y, Shibata T, et al., Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 2008; 68: 5104-5112.
52. Jiang Z, Deng T, Jones RE, et al., Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest 2010; 120: 3296-3309.
53. Kim T, Veronese A, Pichiorri F, et al., p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208: 875-883.
54. Dong P, Karaayvaz M, Jia N, et al., Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene 2013; 32: 3286-3295.
55. Qiu W, Hu M, Sridhar A, et al., No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Gen 2008; 40: 650-655.